↓ Skip to main content

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.996080
Pubmed ID
Authors

Wentao Si, Xiaodan Xu, Lijuan Wan, Fengxu Lv, Wei Wei, Xiaojun Xu, Wei Li, Dabing Huang, Leisheng Zhang, Feifei Li

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 1 13%
Unknown 7 88%
Readers by discipline Count As %
Unknown 8 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2022.
All research outputs
#17,881,371
of 26,178,577 outputs
Outputs from Frontiers in oncology
#8,278
of 22,922 outputs
Outputs of similar age
#288,133
of 499,594 outputs
Outputs of similar age from Frontiers in oncology
#595
of 1,521 outputs
Altmetric has tracked 26,178,577 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,922 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 499,594 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,521 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.